Home  >  Investors  >  Events & Presentations  >  Corporate Presentations

Events & Presentations

Date Title File
Aug 02, 2022
Q2 2022 Financial and Corporate Update Presentation
Jul 19, 2022
Opzelura™ in Vitiligo FDA Approval Presentation
May 03, 2022
Q1 2022 Financial and Corporate Update Presentation
Feb 08, 2022
Q4 2021 Financial and Corporate Update Presentation
Jan 10, 2022
J.P. Morgan 40th Annual Virtual Healthcare Conference
Nov 13, 2021
SITC 2021: Corporate Presentation on Oral PD-L1 Program
Nov 02, 2021
Q3 2021 Financial and Corporate Update Presentation
Sep 27, 2021
GVHD Update Presentation
Sep 22, 2021
Opzelura™ (ruxolitinib) cream FDA Approval Presentation
Aug 03, 2021
Q2 2021 Financial and Corporate Update Presentation